The Smoothbeam laser employs a combination of laser light at 1450 nm and cryogen spray cooling.
The laser light heats the dermis, sebaceous glands, and associated structures within the dermis. The cryogen cooling allows preservation of the epidermis, thus minimizing treatment side effects. The mechanism of action in the treatment of acne is the thermal alteration of the sebaceous glands, which is the cause of pathogenesis of acne lesions.
Smoothbeam treats acne by targeting the sebaceous glands, the root cause of acne.
Student's t-test (paired samples) was performed comparing the difference in acne lesion count at each follow-up time point from the count at baseline on the treatment side with that on the control side. At each of the follow-up time points, a statistically and clinically significant reduction in lesion count is seen on the treatment side compared to the control side with p < 0.001.Proven Effective in Clinical Studies Smoothbeam Compared to Alternative Therapies
A continuous reduction in acne lesions was observed on the treatment side, while only small changes occurred on the control side. At the 6-week follow-up, there was a 98% reduction in mean lesion count on the treatment side as opposed to 12% reduction on the control side. Similarly, at the 12-week follow-up, there was a 98% reduction in the mean lesion count on the treatment side as opposed to 8% reduction on the control side. Furthermore, 98% reduction in mean lesion count on the treatment side while 3% reduction on the control side was observed for the 17 subjects who had their 24-week follow-up. At the 24-week follow-up, 16 of the 17 subjects had zero lesions on the treated side.
Smoothbeam initiates deposition of new collagen to raise depressions in the skin; reducing the appearance of wrinkles and acne scars.